Law360, New York (August 06, 2004) -- A federal district court has upheld the validity of a patent for Irish drug maker Warner Chilcott’s pre-menstrual dysphoric disorder treatment Sarafem, rejecting a challenge by Israeli generics maker Teva Pharmaceuticals.
In a 90-page decision, Chief Judge Sarah Barker of the U.S. District Court for the Southern District of Indiana found in favor of Lilly and Warner Chilcott, and upheld the...
